Empowered Funds, LLC Gilead Sciences, Inc. Transaction History

Empowered Funds, LLC

$5.56 Billion
Q2 2024

A detailed history of Empowered Funds, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Empowered Funds, LLC holds 244,518 shares of GILD stock, worth $21.5 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

244,518

Previous 195,726 24.93%

Holding current value

$21.5 Million

Previous $14.3 Million 17.02%

% of portfolio

0.3%

Previous 0.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$63.15 - $72.88 $3.08 Million - $3.56 Million	48,792 Added 24.93%	244,518 $16.8 Million
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $8.84 Million - $10.8 Million	123,445 Added 170.78%	195,726 $14.3 Million
Q3 2023 Nov 01, 2023	BUY	$73.94 - $80.67 $3.4 Million - $3.7 Million	45,916 Added 174.16%	72,281 $5.42 Million
Q2 2023 Jul 27, 2023	SELL	$76.01 - $86.7 $1.18 Million - $1.35 Million	-15,518 Reduced 37.05%	26,365 $2.03 Million
Q1 2023 Apr 05, 2023	BUY	$77.31 - $88.08 $2.84 Million - $3.24 Million	36,732 Added 713.1%	41,883 $3.48 Million
Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $321,010 - $460,859	5,151 New	5,151 $442,000
Q1 2022 Apr 21, 2022	SELL	$57.92 - $72.58 $3.87 Million - $4.85 Million	-66,876 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $4.34 Million - $4.92 Million	66,876 New	66,876 $4.86 Million
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $2.5 Million - $2.85 Million	-44,117 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$62.1 - $78.08 $583,491 - $733,639	9,396 Added 27.06%	44,117 $2.79 Million
Q2 2020 Jul 16, 2020	SELL	$72.34 - $84.0 $227,653 - $264,348	-3,147 Reduced 8.31%	34,721 $2.67 Million
Q1 2020 Jul 16, 2020	BUY	$62.63 - $80.22 $619,160 - $793,054	9,886 Added 35.33%	37,868 $2.83 Million
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $619,160 - $793,054	-9,886 Reduced 26.11%	27,982 $2.09 Million
Q4 2019 Jan 27, 2020	BUY	$61.62 - $67.78 $253,812 - $279,185	4,119 Added 12.2%	37,868 $2.46 Million
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $6,251 - $6,900	100 Added 0.3%	33,749 $2.14 Million
Q2 2019 Jul 09, 2019	SELL	$61.87 - $69.38 $354,948 - $398,033	-5,737 Reduced 14.57%	33,649 $2.27 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $335,160 - $375,468	5,360 Added 15.75%	39,386 $2.56 Million
Q4 2018 Jan 22, 2019	SELL	$60.54 - $79.0 $553,698 - $722,534	-9,146 Reduced 21.19%	34,026 $2.13 Million
Q3 2018 Oct 18, 2018	SELL	$71.28 - $78.92 $31,933 - $35,356	-448 Reduced 1.03%	43,172 $3.31 Million
Q2 2018 Jul 09, 2018	BUY	$64.88 - $75.68 $165,963 - $193,589	2,558 Added 6.23%	43,620 $3.07 Million
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $740,272 - $902,474	10,163 Added 32.89%	41,062 $3.07 Million
Q4 2017 Jul 09, 2018	BUY	$71.15 - $83.52 $2.2 Million - $2.58 Million	30,899 New	30,899 $2.21 Million
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $1.53 Million - $1.8 Million	-21,522 Closed	0 $0
Q3 2017 Jul 09, 2018	BUY	$72.11 - $85.47 $1.55 Million - $1.84 Million	21,522 New	21,522 $1.74 Million
Q3 2017 Oct 31, 2017	SELL	$72.11 - $85.47 $1.82 Million - $2.16 Million	-25,285 Closed	0 $0
Q2 2017 Jul 09, 2018	BUY	N/A	25,285 New	25,285 $1.79 Million
Q2 2017 Aug 08, 2017	SELL	N/A	-22,497 Closed	0 $0
Q1 2017 Jul 09, 2018	BUY	N/A	22,497	22,497 $1.53 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Account

Empowered Funds, LLC Gilead Sciences, Inc. Transaction History